Formidable Asset Management
WST icon

Formidable Asset Management’s West Pharmaceutical WST Stock Holding History

Formidable Asset Management’s Portfolio WST Stock Details WST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$597K Buy
+1,610
New +$568K 0.09% 210
2025
Q1 		– Sell
-2,067
Closed -$677K – 406
2024
Q4 		$677K Buy
2,067
+55
+3% +$17.3K 0.11% 179
2024
Q3 		$604K Sell
2,012
-120
-6% -$36.8K 0.1% 195
2024
Q2 		$702K Buy
2,132
+65
+3% +$23K 0.11% 176
2024
Q1 		$818K Buy
+2,067
New +$765K 0.13% 158
2023
Q4 		– Sell
-2,225
Closed -$835K – 315
2023
Q3 		$835K Buy
2,225
+144
+7% +$55.7K 0.18% 101
2023
Q2 		$796K Buy
2,081
+956
+85% +$342K 0.17% 111
2023
Q1 		$390K Sell
1,125
-745
-40% -$218K 0.08% 198
2022
Q4 		$440K Hold
1,870
– – 0.1% 179
2022
Q3 		$460K Buy
1,870
+44
+2% +$13.4K 0.11% 169
2022
Q2 		$552K Sell
1,826
-710
-28% -$231K 0.12% 154
2022
Q1 		$1.04M Buy
2,536
+158
+7% +$61.9K 0.2% 95
2021
Q4 		$1.12M Buy
2,378
+237
+11% +$102K 0.21% 90
2021
Q3 		$909K Buy
+2,141
New +$903K 0.17% 112

Other funds holding WST

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.32T AUM 44.66% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $608B AUM 32.77% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $551B AUM 33.95% 1-Year Est. Return
ProShare Advisors
ProShare Advisors Bethesda, Maryland $69.5B AUM 31.38% 1-Year Est. Return
Nuveen
Nuveen Charlotte, North Carolina $420B AUM 34.97% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $362B AUM 34.89% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $30.8B AUM 33.92% 1-Year Est. Return
DekaBank Deutsche Girozentrale
DekaBank Deutsche Girozentrale Frankfurt, Germany $87.8B AUM 20.94% 1-Year Est. Return
Amundi
Amundi Paris, France $496B AUM 35.36% 1-Year Est. Return

Formidable Asset Management's WST Position: Q3 2026 in Review

Formidable Asset Management opened a new position in West Pharmaceutical (WST) in Q3 2026: 1,610 shares worth $597K. The stake represents 0.09% of the portfolio and ranks #210 among its holdings. This is a return to the name: Formidable Asset Management previously reported a position in WST as recently as Q4 2024.

Formidable Asset Management first reported a position in WST in Q3 2021 and has held it in 14 quarters since. The position peaked at $1.12M in Q4 2021. 482 funds tracked by Wall St. Rank hold WST as of Q3 2026.

  • Formidable Asset Management held 1,610 shares of West Pharmaceutical worth $597K as of Q3 2026.
  • West Pharmaceutical was a new Formidable Asset Management position in Q3 2026.
  • West Pharmaceutical made up 0.09% of Formidable Asset Management's portfolio in Q3 2026, its #210 holding.
  • Formidable Asset Management first reported a position in West Pharmaceutical in Q3 2021 and has held it in 14 quarters since.
  • Formidable Asset Management's West Pharmaceutical position peaked at $1.12M in Q4 2021.
  • 482 funds tracked by Wall St. Rank held West Pharmaceutical as of Q3 2026.

Based on Formidable Asset Management's 13F filing for Q3 2026, filed 3 Nov 2026.